The ruling was a milestone in yearslong efforts to make the OxyContin manufacturer pay for its role in the opioid crisis, but some plaintiffs feel the plan doesn’t go far enough.
Published: May 27, 2021 at 12:53AM
from NYT Health https://ift.tt/3hVRIZv